[Federal Register Volume 65, Number 26 (Tuesday, February 8, 2000)]
[Notices]
[Pages 6212-6213]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-2906]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Meeting of the Secretary's Advisory Committee on Genetic Testing

AGENCY:  Office of the Secretary, DHHS.

ACTION:  Notice of meeting.

-----------------------------------------------------------------------

[[Page 6213]]

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Secretary's Advisory Committee on Genetic Testing (SACGT), U.S. 
Public Health Service. The meeting will be held at the International 
Trade Center, Polaris Ballroom, 1300 Pennsylvania Avenue, NW, 
Washington, DC 20004, starting on February 24, 2000, at approximately 
9:00 a.m. and will recess at approximately 5:30 p.m. The meeting will 
reconvene on February 25, 2000, at approximately 8:00 a.m. and will 
adjourn at approximately 5:00 p.m. The meeting will be open to the 
public. Attendance by the public will be limited by the space 
available. The committee will review public comments received in 
response to A Public Consultation on Oversight of Genetic Tests 
published in the Federal Register on December 1, 1999 (64 FR 67273), 
and work toward the development of final recommendations on the 
oversight of genetic testing. A limited period of time will be provided 
for public comment, and individuals interested in participating in the 
public comment period should contact Ms. Sarah Carr, SACGT Executive 
Secretary, as shown below.
    Under authority of 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
(DHHS) established the SACGT to advise and make recommendations to the 
Secretary through the Assistant Secretary for Health on all aspects of 
the development and use of genetic tests. The SACGT is directed to: (1) 
Recommend policies and procedures for the safe and effective 
incorporation of genetic technologies into health care; (2) assess the 
effectiveness of existing and future measures for oversight of genetic 
tests; (3) and identify research needs related to the Committee's 
purview.
    Further information about the SACGT is available at the following 
web site: http://www4.od.nih.gov/oba/sacgt.htm. If you wish to attend, 
please register through the web site. A draft meeting agenda will be 
posted to the web site prior to the meeting. Individuals who wish to 
provide public comments should notify Ms. Carr, by telephone at 301-
496-9838 or E-mail at <a href="/cdn-cgi/l/email-protection#71021240404312311f18195f161e07"><span class="__cf_email__" data-cfemail="8efdedbfbfbcedcee0e7e6a0e9e1f8">[email protected]</span></a> as soon as possible and provide a 
copy of their remarks to Ms. Carr by February 15, 2000. Those who plan 
to attend the meeting and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
notify Ms. Carr at 301-496-9838. The SACGT office is located at 6000 
Executive Boulevard, Suite 302, Bethesda, Maryland 20892.

    Dated: February 3, 2000.
Sarah Carr,
Executive Secretary, SACGT.
[FR Doc. 00-2906 Filed 2-7-00; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>